Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE)
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE)
HYDERABAD, INDIA – Media OutReach Newswire – 4 January 2024 – ACCESS Health International, a globally recognized health systems think
Study reveals 75 percent of the world’s industrial fishing vessels are hidden from public view WASHINGTON, D.C., Jan. 03, 2024
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology
Foothill Ranch, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Sweegen, the global leader in pioneering wellness ingredient and taste modulation
FMF strengthens the Kingdom’s leadership in enabling the Super Region to contribute to the metals industries of the future RIYADH,
NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers
NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers